Nasal Drug Delivery Research Report with Outlook, Strategies, Business Growth, Applications and Forecast 2027
Rapid development in the medical field and pharmaceutical
industry is leading to the introduction of highly effective and innovative
modes of drug administration systems for treating various medical conditions.
Nasal drug delivery system is utilized for the treatment of local infections
such as allergies, sinusitis, rhinitis, and others in the nasal course or
paranasal sinuses.
The report published by Market Research Future (MRFR) states
that the Middle East and Africa nasal
drug delivery market is marked to exhibit noteworthy expansion at a CAGR of
8.1% during the forecast period of 2015-2022 and reach the market valuation of
USD 1.59 Bn by the end of the assessment period form USD 1 Bn in the year 2015.
High prevalence of viral infections that causes blockage of the nasal cavity
and respiratory disorders are inducing high demand for advanced treatment in
the global market, leading to the expansion of the Middle East and Africa nasal
drug delivery market.
Increased availability of treatment solutions and
proliferation in government initiative to provide treatment in the remote areas
due to high unmet medical needs of the population in these areas are also
propelling the growth of the Middle East and Africa nasal drug delivery market
during the assessment period.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/2696
Competitive Analysis:
Some of the major players profiled by Market Research Future
(MRFR) that are operating in the global drug delivery market are Novartis AG,
Pfizer, Inc., Sanofi-Aventis, GlaxoSmithKline Plc, Merck & Co., Inc.,
AptarGroup Inc., Johnson & Johnson Services, Inc., Becton Dickson &
Company and others. The players in the Middle East and Africa nasal drug
delivery market are focusing on the expansion of their business on a global
level by increasing research expenditure for the development of advanced
treatment solution and innovative modes of drug administration. Initiatives
such as strategically planned mergers and acquisitions are aiding the players
to sustain the competition and retain their dominance over the Middle East and
Africa nasal drug delivery market during the assessment period.
Segmental Analysis:
The Middle East and Africa nasal drug delivery market is
segmented on the basis of dosage form, system, delivery technology, and
therapeutic applications. Based on dosage form, the Middle East and Africa
nasal drug delivery market has been segmented into drops, sprays, powder, gels,
and ointments. Based on system, the Middle East and Africa nasal drug delivery
market has been segmented into unit dose, multi-dose, and metered dose. Based
on delivery technologies, the Middle East and Africa nasal drug delivery market
has been segmented into spray, nebulizers and other. Based on therapeutic
applications, the Middle East and Africa nasal drug delivery market has been
segmented into rhinitis, congestion, vaccinations and others.
Regional Analysis:
Geographically, the Middle East and Africa nasal drug
delivery market has been segmented into six major countries such as the UAE,
Egypt, Saudi Arabia, Kuwait, Qatar, and Oman. Among these, the nasal drug
delivery market in the UAE commands the major share of the Middle East and
Africa nasal drug delivery market owing to the presence of well-developed
healthcare infrastructure, high healthcare expenditure by the population of
this area, increasing availability of vaccinations and other treatment options
and high demand for advanced mode of drug administration in this country. Egypt
commands the second largest share of the Middle East and Africa nasal drug
delivery market owing to the increasing awareness regarding the availability of
treatments for nasal infections, presence of developed healthcare sector as
this country attracts a large number of international tourists who require
proper healthcare and proliferation in government initiative to provide optimum
healthcare solutions in this country. Low penetration of healthcare facilities
and lack of awareness in the remote areas of the Africa region are leading to
the slow growth of the nasal drug delivery market in this region. However,
increased government support for providing healthcare facilities in such areas
due to high unmet medical needs of the population is contributing to the
expansion of the nasal drug delivery market in this region.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment